SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John O'Neill who wrote (298)3/21/1998 11:46:00 PM
From: Ian@SI  Read Replies (1) of 1321
 
John,

I see you found this thread...

The recent decline was due in part at least to their earnings release. It contained a note indicating that a charge was taken for the return of expired Photofrin in the United States, implying that the cancer treatment is not being avidly adopted at this point.

If you read some of the earlier posts, you'll see the matter discussed in some detail. At that time there were downgrades by some of the Canadian brokers following the stock.

More recently, the news has been of a positive nature.

Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext